A phase II study of combination therapy with liposomal doxorubicin and carboplatin (CBDCA) in patients (pts) with previously untreated small cell lung cancer (SCLC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: D. A. Vorobiof, B. L. Rapoport, C. F. Slabber, A. S. Alberts, A. Uys
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590911405
